Patients with primary osteoporosis
Conditions
Interventions
The clinics were randomized into two groups according to the dosing protocol, monthly bisphosphonate (3 months) followed by weekly bisphosphonate (3 months) or weekly bisphosphonate (3 months) followe
Sponsors
Clinical practice-based osteoporosis conference
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: The inclusion criteria were age more than 50 years, a fully ambulatory status, a diagnosis of primary osteoporosis according to the Japanese diagnostic criteria and an osteoporosis treatment-naive status.
Exclusion criteria
Exclusion criteria: The exclusion criteria were a history of reflux esophagitis, gastric or duodenal ulcer, gastrectomy, renal failure, or bone diseases including cancer-induced bone loss, primary hyperparathyroidism, hyperthyroidism, Cushing syndrome, multiple myeloma, Paget's disease of the bone, rheumatoid arthritis, or osteogenesis imperfecta.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Patient preference for either monthly bisphosphonate regimen or weekly bisphosphonate regimen among patients responding to the questionnaire after 6-month of treatment with monthly bisphosphonate (3-month) and weekly bisphosphonate (3-month) | — |
Secondary
| Measure | Time frame |
|---|---|
| Convenience of monthly bisphosphonate regimen compared tih weekly bisphosphonate regimen among patients responding to the questionnaire | — |
Countries
Japan
Contacts
Public ContactJun Iwamoto
Keio University School of Medicine Institute for Integrated Sports Medicine
Outcome results
None listed